Eleven Biotherapeutics Inc. is changing its name to Sesen Bio Inc.
The company's shares will start trading under the new name and Nasdaq ticker symbol SESN, effective May 17.
Eleven Biotherapeutics is a biologic oncology company that focuses on the design and development of targeted protein therapeutics addressing areas of unmet medical needs in cancer.
